Liver cancer
Conditions
Interventions
Experimental group:Low central venous pressure technology
Control group:normal CVP
Sponsors
Hu'nan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 60 years; 2. Body mass index within the normal range (1+/-20%); 3. Preoperative diagnosis must meet the relevant standards in the 2011 version of the primary liver cancer diagnosis and treatment specifications, and postoperative pathology The result was hepatocellular carcinoma; 4. ASA I-II; 5. Before the trial, the patient or his legal representative understood and voluntarily signed an informed consent form approved by the ethics committee.
Exclusion criteria
Exclusion criteria: 1. Participated in other clinical trials within 4 weeks before the start of this study; 2. No hepatic portal block was required during the operation; 3. Severe liver and kidney insufficiency; 4. Cases of severe heart, brain and lung diseases and hypertension; 5. Tumor diameter > 10 cm; 6. Patients who are unwilling to participate in this study for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complication; | — |
Secondary
| Measure | Time frame |
|---|---|
| Arachidonic acid-lipoxygenase; | — |
Countries
China
Contacts
Public ContactYang Jinfeng
Anesthesia Surgery Center of Hu'nan Cancer Hospital
Outcome results
None listed